跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
鄭 景泉
助理教授
,
胸腔內科
主治醫師
,
衛生福利部雙和醫院
成員
,
臺北醫學大學胸腔醫學研究中心
https://orcid.org/0000-0002-2734-9988
電子郵件
16044
s.tmu.edu
tw
h-index
366
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2024
每年研究成果
概覽
指紋
網路
專案
(5)
研究成果
(34)
類似的個人檔案
(6)
指紋
查看啟用 Jing-Quan Zheng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Chronic Kidney Disease
100%
Cohort Analysis
50%
Influenza Vaccination
50%
Diabetes Mellitus
41%
Kidney Function
38%
COVID-19
32%
Lung Cancer
29%
Deterioration
28%
Clear Cell Renal Cell Carcinoma
25%
Acute Kidney Injury
25%
Medicine
25%
Vitamin D
25%
Diabetic Retinopathy
25%
Hazard Ratio
24%
Patient with Diabetes
19%
Infection
18%
Osteolysis
15%
Malignant Neoplasm
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Prevalence
15%
Disease Exacerbation
14%
down Regulation
14%
Autophagy
14%
Hip Fracture
13%
Nodular Melanoma
12%
Absence
12%
Liver Cancer
12%
Lung Adenocarcinoma
12%
Programmed Cell Death
12%
Blood Vessel Calcification
12%
Patient with Hypertension
12%
Angiotensin Receptor Antagonist
12%
ACE Inhibitor
12%
Boron 10
12%
Cinacalcet
12%
Body Mass Index
12%
Inflammatory Disorder
12%
Metabolic Acidosis
12%
Monotherapy
12%
Risk Factor for Myopia
12%
Water-Electrolyte Imbalance
12%
Apoplexy
12%
4 Iodo 2,5 Dimethoxyamphetamine
12%
Upregulation
12%
Inositol
12%
Lactic Acidosis
12%
Glioblastoma
12%
Temozolomide
12%
Antiviral Therapy
12%
Osteoclast
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
75%
Deterioration
39%
Disease
36%
Coronavirinae
34%
Diabetes Mellitus
30%
Cohort Study
29%
Hemodialysis
28%
Vitamin D
26%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Angiotensin Receptor Antagonist
25%
Lung Cancer
25%
Renal Cell Carcinoma
25%
Acute Kidney Failure
25%
Cholecalciferol
25%
Parathyroid Hormone
25%
Cinacalcet
25%
Monotherapy
25%
Vaccination Policy
25%
Diabetic Retinopathy
25%
Disease Exacerbation
18%
Infection
18%
Secondary Hyperparathyroidism
17%
SARS Coronavirus
17%
Inflammation
15%
Cathelicidin
14%
Inositol
12%
Docetaxel
12%
Castration Resistant Prostate Cancer
12%
Boron 10
12%
Paricalcitol
12%
Antiviral Therapy
12%
Ropeginterferon Alpha2b
12%
Lactoferrin
12%
Metabolic Disorder
12%
Sleep Disordered Breathing
12%
Calcitriol
12%
Angiotensin Converting Enzyme 2
12%
DNA Polymerase
12%
Metabolic Acidosis
12%
Lactic Acidosis
12%
Off-Label Use
12%
Hypermetropia
12%
Macular Degeneration
12%
Age Related Macular Degeneration
11%
Intestine Flora
8%
Angiotensin
8%
Kidney Disease
7%
Dysbiosis
7%
Hyperglycemia
6%
Lagerstroemia
6%
Biochemistry, Genetics and Molecular Biology
Autophagy
35%
Hemodialysis
31%
Upregulation
27%
Vitamin D
26%
down Regulation
25%
Parathyroid Hormone Blood Level
25%
Cholecalciferol
25%
Prevalence
20%
Autophagosome
15%
Cathelicidin
14%
Messenger RNA
13%
Mammalian Target of Rapamycin
13%
Kidney Function
12%
Calcitriol
12%
Drive
12%
Inositol Monophosphatase
12%
E2F
12%
Cardiovascular Mortality
12%
Paricalcitol
12%
Body Mass
12%
Parathyroid Hormone
12%
Cell Death
12%
DNA Polymerase
12%
Phospholipase C
12%
Histone H2A
12%
Luciferase
9%
Survival Rate
9%
Cell Invasion
9%
Coronavirinae
9%
Reverse Transcription Polymerase Chain Reaction
8%
Cohort Study
8%
SARS Coronavirus
7%
T Cell
7%
Cell Migration
7%
Cancer Cell
7%
Progression Free Survival
6%
All Cause Mortality
6%
Somnolence
6%
Pulse Rate
6%
Inflammasome
6%
Gene Set Enrichment Analysis
5%
STAT3
5%
